ED
ILMN icon

Exane Derivatives’s Illumina ILMN Stock Holding History

Exane Derivatives’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$369 Sell
2
-61
-97% -$15.6K ﹤0.01% 605
2022
Q1 		$21.3K Sell
63
-5
-7% -$1.69K 0.01% 659
2021
Q4 		$25.1K Sell
68
-203
-75% -$76.9K 0.01% 564
2021
Q3 		$107K Sell
271
-81
-23% -$37.3K 0.03% 516
2021
Q2 		$165K Sell
352
-142
-29% -$57.2K 0.04% 448
2021
Q1 		$185K Sell
494
-287
-37% -$117K 0.05% 313
2020
Q4 		$281K Sell
781
-744
-49% -$237K 0.08% 257
2020
Q3 		$458K Buy
1,525
+35
+2% +$12.1K 0.13% 142
2020
Q2 		$537K Buy
1,490
+1,236
+487% +$398K 0.14% 124
2020
Q1 		$67.5K Sell
254
-52
-17% -$14.5K 0.02% 330
2019
Q4 		$95.4K Hold
306
– – 0.02% 324
2019
Q3 		$90.6K Hold
306
– – 0.02% 324
2019
Q2 		$110K Hold
306
– – 0.02% 324
2019
Q1 		$92.5K Buy
306
+172
+128% +$50.2K 0.02% 303
2018
Q4 		$39K Buy
134
+133
+13,300% +$41.2K 0.01% 383
2018
Q3 		$367 Hold
1
– – ﹤0.01% 586
2018
Q2 		$279 Hold
1
– – ﹤0.01% 586
2018
Q1 		$235 Hold
1
– – ﹤0.01% 529
2017
Q4 		$218 Sell
1
-1
-50% -$206 ﹤0.01% 519
2017
Q3 		$398 Sell
2
-4
-67% -$745 ﹤0.01% 476
2017
Q2 		$1.04K Hold
6
– – ﹤0.01% 472
2017
Q1 		$1.02K Sell
6
-44,739
-100% -$7.05M ﹤0.01% 413
2016
Q4 		$5.57M Buy
44,745
+44,744
+4,474,400% +$6.03M 1.1% 12
2016
Q3 		$182 Hold
1
– – ﹤0.01% 513
2016
Q2 		$140 Hold
1
– – ﹤0.01% 459
2016
Q1 		$162 Hold
1
– – ﹤0.01% 510
2015
Q4 		$192 Hold
1
– – ﹤0.01% 435
2015
Q3 		$176 Hold
1
– – ﹤0.01% 470
2015
Q2 		$218 Hold
1
– – ﹤0.01% 473
2015
Q1 		$186 Buy
+1
New +$188 ﹤0.01% 476

Other funds holding ILMN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's ILMN Position: Q2 2022 in Review

Exane Derivatives reduced its Illumina (ILMN) stake by 97% in Q2 2022, selling an estimated $15.6K and leaving 2 shares worth $369. The position accounts for ﹤0.01% of the portfolio, ranked #605.

Exane Derivatives first reported a position in ILMN in Q1 2015 and has held it in 30 quarters since. The position peaked at $5.57M in Q4 2016. 912 funds tracked by Wall St. Rank hold ILMN as of Q2 2022.

  • Exane Derivatives held 2 shares of Illumina worth $369 as of Q2 2022.
  • Exane Derivatives sold 61 Illumina shares in Q2 2022, an estimated $15.6K.
  • Illumina made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #605 holding.
  • Exane Derivatives first reported a position in Illumina in Q1 2015 and has held it in 30 quarters since.
  • Exane Derivatives's Illumina position peaked at $5.57M in Q4 2016.
  • 912 funds tracked by Wall St. Rank held Illumina as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.